Search research articles
Contact Us
Filters
Showing results (311-320 of 455) with videos related to
Page
of 46
Sort By:
NAR Cancer
|
April 7, 2025
Identification of FLYWCH1 as a regulator of platinum-resistance in epithelial ovarian cancer
Tabea L Fullstone, Helene Rohm, Till Kaltofen, et al.
Histology and Histopathology
|
March 24, 2025
A low nuclear-to-cytoplasmic ratio of VDR expression is an independent prognostic marker in breast cancer
Charlotte Schubert, Theresa Vilsmaier, Falk Batz, et al.
International Journal of Molecular Sciences
|
November 27, 2021
Regulation of Epigenetic Modifications in the Placenta during Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells
Sarah Meister, Laura Hahn, Susanne Beyer, et al.
Journal of Reproductive Immunology
|
February 5, 2021
Interleukin-1 beta is significantly upregulated in the decidua of spontaneous and recurrent miscarriage placentas
Sanja Löb, Niklas Amann, Christina Kuhn, et al.
Journal of Gynecologic Oncology
|
March 20, 2019
A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patients
Theresa Maria Kolben, Lea T Etzel, Florian Bergauer, et al.
Gynecologic Oncology
|
October 5, 2014
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer
Evelyn Despierre, Matthieu Moisse, Betül Yesilyurt, et al.
Journal of Reproductive Immunology
|
March 4, 2021
Epigenetic modification via H3K4me3 and H3K9ac in human placenta is reduced in preeclampsia
Sarah Meister, Laura Hahn, Susanne Beyer, et al.
Archives of Gynecology and Obstetrics
|
September 1, 2018
Participation of elderly gynecological cancer patients in clinical trials
Katharina Prieske, Fabian Trillsch, Gülten Oskay-Özcelik, et al.
Journal of Cancer Research and Clinical Oncology
|
June 21, 2022
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Thomas Kolben, Lena Müller, Sarah Meister, et al.
Cancers
|
August 29, 2019
Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer
Katharina Dötzer, Friederike Schlüter, Markus Bo Schoenberg, et al.
Page
of 46
Search research articles
Search
Showing results (311-320 of 455) with videos related to
Sort By:
Page
of 46
NAR Cancer
|
April 7, 2025
Identification of FLYWCH1 as a regulator of platinum-resistance in epithelial ovarian cancer
Tabea L Fullstone, Helene Rohm, Till Kaltofen, et al.
Histology and Histopathology
|
March 24, 2025
A low nuclear-to-cytoplasmic ratio of VDR expression is an independent prognostic marker in breast cancer
Charlotte Schubert, Theresa Vilsmaier, Falk Batz, et al.
International Journal of Molecular Sciences
|
November 27, 2021
Regulation of Epigenetic Modifications in the Placenta during Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells
Sarah Meister, Laura Hahn, Susanne Beyer, et al.
Journal of Reproductive Immunology
|
February 5, 2021
Interleukin-1 beta is significantly upregulated in the decidua of spontaneous and recurrent miscarriage placentas
Sanja Löb, Niklas Amann, Christina Kuhn, et al.
Journal of Gynecologic Oncology
|
March 20, 2019
A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patients
Theresa Maria Kolben, Lea T Etzel, Florian Bergauer, et al.
Gynecologic Oncology
|
October 5, 2014
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer
Evelyn Despierre, Matthieu Moisse, Betül Yesilyurt, et al.
Journal of Reproductive Immunology
|
March 4, 2021
Epigenetic modification via H3K4me3 and H3K9ac in human placenta is reduced in preeclampsia
Sarah Meister, Laura Hahn, Susanne Beyer, et al.
Archives of Gynecology and Obstetrics
|
September 1, 2018
Participation of elderly gynecological cancer patients in clinical trials
Katharina Prieske, Fabian Trillsch, Gülten Oskay-Özcelik, et al.
Journal of Cancer Research and Clinical Oncology
|
June 21, 2022
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Thomas Kolben, Lena Müller, Sarah Meister, et al.
Cancers
|
August 29, 2019
Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer
Katharina Dötzer, Friederike Schlüter, Markus Bo Schoenberg, et al.
Page
of 46